E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/24/2012 in the Prospect News PIPE Daily.

BioCurex takes in $576,632 through private placement of common stock

84,684,615 common shares sold at $0.007 per share in offering

By Devika Patel

Knoxville, Tenn., Aug. 24 - BioCurex Inc. completed a $576,632 private placement of stock, according to an 8-K filed Friday with the Securities and Exchange Commission.

The company sold 84,684,615 common shares at about $0.007 per share during the twelve months ended Aug. 31.

BioCurex is a Richmond, B.C., biotechnology company focused on cancer diagnosis, imaging and therapy.

Issuer:BioCurex Inc.
Issue:Common stock
Amount:$576,632
Shares:84,684,615
Price:$0.007 (approximate)
Warrants:No
Announcement date:Aug. 24
Stock symbol:OTCBB: BOCX

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.